| Title |
Barbiturates for acute traumatic brain injury
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd000033.pub2 |
| Pubmed ID | |
| Authors |
Ian Roberts, Emma Sydenham |
| Abstract |
Raised intracranial pressure (ICP) is an important complication of severe brain injury, and is associated with high mortality. Barbiturates are believed to reduce ICP by suppressing cerebral metabolism, thus reducing cerebral metabolic demands and cerebral blood volume. However, barbiturates also reduce blood pressure and may, therefore, adversely effect cerebral perfusion pressure. |
Twitter Demographics
The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Colombia | 1 | <1% |
| Chile | 1 | <1% |
| Switzerland | 1 | <1% |
| Japan | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 184 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 31 | 16% |
| Researcher | 27 | 14% |
| Student > Bachelor | 25 | 13% |
| Student > Ph. D. Student | 18 | 9% |
| Student > Postgraduate | 16 | 8% |
| Other | 39 | 20% |
| Unknown | 35 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 94 | 49% |
| Nursing and Health Professions | 13 | 7% |
| Neuroscience | 10 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
| Psychology | 5 | 3% |
| Other | 22 | 12% |
| Unknown | 40 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2022.
All research outputs
#6,411,756
of 23,202,641 outputs
Outputs from Cochrane database of systematic reviews
#8,201
of 12,392 outputs
Outputs of similar age
#66,885
of 281,153 outputs
Outputs of similar age from Cochrane database of systematic reviews
#112
of 192 outputs
Altmetric has tracked 23,202,641 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,392 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.6. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,153 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 192 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.